• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

沙利度胺治疗麻风反应前后皮肤的铁含量。初步报告。

Iron content of skin before and after thalidomide treatment of lepra reaction. A preliminary report.

作者信息

Sheskin J, Gorodetsky R, Weinreb A, Loewinger E

出版信息

Dermatologica. 1981;163(2):145-50. doi: 10.1159/000250151.

DOI:10.1159/000250151
PMID:7286355
Abstract

THe concentration of copper, zinc and iron in the skin of patients suffering from lepra reaction was measured by diagnostic X-ray spectrometry (DXS) at the sites of the lesions before and after treatment with thalidomide. The results were compared with the levels of these elements in the skin of healthy individuals. No significant changes in the copper level of leprous skin were found. The zinc levels showed significant elevations in some lesions with no apparent trend. The iron level in the affected areas had highly elevated values in all cases of lepra reaction. However, in contrast to the fast clinical improvement which followed the treatment with thalidomide, the iron levels did not decrease for prolonged periods.

摘要

采用诊断X射线光谱法(DXS)测定了沙利度胺治疗前后麻风反应患者皮损部位铜、锌和铁的浓度。将结果与健康个体皮肤中这些元素的水平进行比较。麻风皮肤的铜水平未发现明显变化。锌水平在一些皮损中有显著升高,但无明显趋势。在所有麻风反应病例中,受累区域的铁水平均显著升高。然而,与沙利度胺治疗后临床症状迅速改善形成对比的是,铁水平在较长时间内并未下降。

相似文献

1
Iron content of skin before and after thalidomide treatment of lepra reaction. A preliminary report.沙利度胺治疗麻风反应前后皮肤的铁含量。初步报告。
Dermatologica. 1981;163(2):145-50. doi: 10.1159/000250151.
2
In vivo measurements of iron, copper and zinc in the skin of prurigo nodularis patients treated with thalidomide.使用沙利度胺治疗的结节性痒疹患者皮肤中铁、铜和锌的体内测量。
Dermatologica. 1981;162(2):86-90. doi: 10.1159/000250254.
3
Thalidomide in leprosy--study of 94 cases.沙利度胺治疗麻风病——94例研究。
Indian J Lepr. 1986 Oct-Dec;58(4):560-6.
4
Thalidomide in lepra reaction (ENL) in lepromatous leprosy patients.沙利度胺用于瘤型麻风患者的麻风反应(ENL)。
Indian J Lepr. 1984 Apr-Jun;56(2):264-8.
5
In vivo study of trace elements in leprous skin.
Int J Dermatol. 1977 Nov;16(9):745-7. doi: 10.1111/j.1365-4362.1977.tb01894.x.
6
The treatment of lepra reaction in lepromatous leprosy. Fifteen years' experience with thalidomide.瘤型麻风反应的治疗。沙利度胺十五年应用经验。
Int J Dermatol. 1980 Jul-Aug;19(6):318-22. doi: 10.1111/j.1365-4362.1980.tb00342.x.
7
[World survey on the use of thalidomide in leprosy reaction].[沙利度胺在麻风反应中应用的全球调查]
Med Cutan Ibero Lat Am. 1975;3(1):81-3.
8
Results of a double blind study of the influence of thalidomide on the lepra reaction.沙利度胺对麻风反应影响的双盲研究结果
Int J Lepr Other Mycobact Dis. 1969 Apr-Jun;37(2):135-46.
9
WHO co-ordinated short-term double-blind trial with thalidomide in the treatment of acute lepra reactions in male lepromatous patients.世界卫生组织协调了一项使用沙利度胺治疗男性瘤型麻风患者急性麻风反应的短期双盲试验。
Bull World Health Organ. 1971;45(6):719-32.
10
An open trial with clofazimine in the management of recurrent lepra reaction using thalidomide as a control drug.一项以氯法齐明治疗复发性麻风反应的开放试验,使用沙利度胺作为对照药物。
Lepr India. 1976 Oct;48(4 Suppl):690-4.